Oct 14, 9:14 AM ET
Kulicke and Soffa's compensation committee approved an amended and restated Incentive Compensation Plan on October 13, 2026, effective for fiscal 2027. The plan swaps Net Income and Operating Margin for Operating Profit and Gross Margin as corporate performance measures, and adds an individual goal component for Executive Leadership Team awards. For shareholders, this changes how management bonuses are tied to financial results.
- Corporate performance measures changed from Net Income and Operating Margin (50% each) to Operating Profit and Gross Margin (50% each)
- For fiscal 2027, Executive Leadership Team awards will be 85% based on corporate financial performance and 15% on individual goals
- Business unit scorecards may be tailored by growth phase and strategic priorities, within existing governance
- Plan approved October 13, 2026; filed in Form 8-K dated October 14, 2026
Read the filing on SEC.gov ↗
Aug 17, 5:01 PM ET
Kulicke & Soffa named Dr. Raj Talluri as President and Chief Executive Officer effective September 1, 2026, and elected him to its Board effective August 17, 2026. Interim CEO Lester Wong will remain Executive Vice President and Chief Financial Officer. The filing also sets out Talluri's pay, including a $750,000 base salary and a one-time new-hire equity award with a target value of $14.0 million.
- Talluri becomes President and CEO on September 1, 2026, and joined the Board on August 17, 2026.
- Talluri was President and CEO of Enovix Corporation from January 2023; he was at Micron Technology from March 2018 to December 2022.
- Offer letter terms include a $750,000 base salary, a target bonus of 110% of base salary, and a $6.0 million target annual equity award.
- Lester Wong, interim CEO, continues as Executive Vice President and Chief Financial Officer.
Read the filing on SEC.gov ↗
Aug 5, 4:07 PM ET
Kulicke and Soffa reported fiscal third-quarter 2026 net revenue of $330.4 million, up from $148.4 million a year earlier and $242.6 million in the prior quarter, and GAAP net income of $57.4 million, or $1.07 per diluted share, compared with a loss of $0.06 per share a year earlier. The company expects fourth-quarter net revenue of about $375 million, plus or minus $20 million, and GAAP diluted EPS of about $1.29, plus or minus 10%.
- Net revenue of $330.4 million vs. $148.4 million in fiscal Q3 2025 and $242.6 million in fiscal Q2 2026
- GAAP diluted EPS of $1.07 vs. a loss of $0.06 a year earlier; non-GAAP diluted EPS of $1.20 vs. $0.07
- Fourth-quarter fiscal 2026 outlook: net revenue about $375 million (+/- $20 million), GAAP diluted EPS about $1.29 (+/- 10%)
- Gross margin of 47.8%; repurchased 5.0 thousand shares for $0.5 million; webcast set for August 6, 2026 at 8:00 am ET
Read the filing on SEC.gov ↗
May 6, 4:06 PM ET
Kulicke and Soffa reported fiscal second-quarter 2026 net revenue of $242.6 million and GAAP net income of $35.1 million, or $0.66 per diluted share, compared with a net loss of $84.5 million a year earlier. The company guided third-quarter net revenue to about $310 million, plus or minus $20 million, and said it will increase fiscal 2026 capital expenditure to support Thermo-Compression bonding system production.
- Q2 net revenue of $242.6 million, up from $162.0 million a year earlier and $199.6 million in fiscal Q1 2026
- GAAP diluted EPS of $0.66 versus a loss of $1.59 a year earlier; non-GAAP diluted EPS of $0.79
- Q3 fiscal 2026 outlook: net revenue of about $310 million +/- $20 million, GAAP diluted EPS of about $0.87, non-GAAP diluted EPS of about $1.00
- Fiscal 2026 capital expenditure expected to rise from about $12 million to about $22 million, supporting up to about $400 million in annual TCB system sales
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.